Reports histopathological predictors of progression in IGA nephropathy, suggesting a potential tool for better management.
Conclusion:Early CAG strategy, as compared to medication treatment or a more delayed CAG, in advanced CKD patients presenting with ACS is not associated with increased risk of RRT and may poses a long-term survival benefit.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.
No takes yet. Share an insight, caveat, or question.
Delbet et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: